No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
No Data
No Data
No Data
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Yahoo FinanceApr 26 08:25 ET
Incyte's Strategic Acquisition and Promising Pipeline Secure Buy Rating
TipRanksApr 26 02:16 ET
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates From VRTX
Yahoo FinanceApr 25 14:28 ET
Express News | Incyte : Oppenheimer Cuts Target Price to $84 From $92
Moomoo 24/7Apr 24 08:03 ET
Oppenheimer Sticks to Its Buy Rating for Incyte (INCY)
TipRanksApr 24 07:46 ET
Incyte Price Target Cut to $84.00/Share From $92.00 by Oppenheimer
Incyte Price Target Cut to $84.00/Share From $92.00 by Oppenheimer
Dow JonesApr 24 07:33 ET
No Data
No Data